Yokohama, Japan

Jun Hayakawa

This inventor holds 3 USPTO granted patents, plus 2 CIPO patents. Top assignee: Toray Industries, Inc.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Hayakawa. Retrieved from https://idiyas.com/inventor/jun-hayakawa-1pg9mgy7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 67(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jun Hayakawa: Innovator in Pharmaceutical Applications

Introduction

Jun Hayakawa is a notable inventor based in Yokohama, Japan. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on morphinan derivatives. With a total of 3 patents to her name, she continues to push the boundaries of pharmaceutical science.

Latest Patents

Hayakawa's latest patents include a morphinan derivative and its pharmaceutical applications. This invention focuses on a morphinan derivative or its pharmacologically allowed acid addition salt represented with compound I. Her work in this area has the potential to lead to new therapeutic options in medicine.

Career Highlights

Jun Hayakawa is currently employed at Toray Industries, Inc., where she applies her expertise in pharmaceutical research. Her role at the company allows her to collaborate with other talented professionals in the field, further enhancing her contributions to innovation.

Collaborations

Some of her notable coworkers include Hiroshi Nagase and Koji Kawai. Their collaborative efforts have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Jun Hayakawa is a pioneering inventor whose work in morphinan derivatives is shaping the future of pharmaceuticals. Her dedication to innovation and collaboration continues to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…